Ely Benaim

Net worth: 449 675 $ as of 2024-03-30

63 year

Health Technology

Consumer Services

Profile

Ely Benaim is Chief Medical Officer at NovoCure Ltd. In the past Dr. Benaim occupied the position of Vice President-Clinical Affairs at Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs at Berg Pharma LLC, Senior Director-Clinical Research at Millennium Pharmaceuticals, Inc., Chief Medical Officer of Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology at Salmedix, Inc. and Assistant Professor at the University of Tennessee. Dr. Benaim received a doctorate from Central University of Venezuela.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NOVOCURE LTD. 0.03%	2023-01-05	28,770 ( 0.03% )	449 675 $	2024-03-30

Former positions of Ely Benaim

Companies	Position	End
NOVOCURE LIMITED	Chief Tech/Sci/R&D Officer	2023-01-16
REXAHN PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2019-03-30
Berg Pharma LLC	Chief Tech/Sci/R&D Officer	2014-12-31
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	2012-12-31
SANGAMO THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2009-12-31

See the detail of Ely Benaim's experience

Training of Ely Benaim

Central University of Venezuela

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ely Benaim's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SANGAMO THERAPEUTICS, INC.	Health Technology
NOVOCURE LIMITED	Health Technology

Private companies	4
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Health Technology
Salmedix, Inc. Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA.	Health Technology
Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.	Health Technology
Berg Pharma LLC

See company connections